Glottic Visibility for Laryngeal Surgery: Tritube Vs. Microlaryngeal Tube: A Randomised Controlled Trial
Overview
Authors
Affiliations
Background: Good visibility is essential for successful laryngeal surgery. A Tritube with outer diameter 4.4 mm, combined with flow-controlled ventilation (FCV), enables ventilation by active expiration with a sealed trachea and may improve laryngeal visibility.
Objectives: We hypothesised that a Tritube with FCV would provide better laryngeal visibility and surgical conditions for laryngeal surgery than a conventional microlaryngeal tube (MLT) with volume-controlled ventilation (VCV).
Design: Randomised, controlled trial.
Setting: University Medical Centre.
Patients: A total of 55 consecutive patients (>18 years) undergoing elective laryngeal surgery were assessed for participation, providing 40 evaluable data sets with 20 per group.
Interventions: Random allocation to intubation with Tritube and ventilation with FCV (Tritube-FCV group) or intubation with MLT 6.0 and ventilation with VCV (MLT-VCV) as control. Tidal volumes of 7 ml kg predicted body weight, and positive end-expiratory pressure of 7 cmH2O were standardised between groups.
Main Outcome Measures: Primary endpoint was the tube-related concealment of laryngeal structures, measured on videolaryngoscopic photographs by appropriate software. Secondary endpoints were surgical conditions (categorical four-point rating scale), respiratory variables and change of end-expiratory lung volume from atmospheric airway pressure to ventilation with positive end-expiratory pressure. Data are presented as median [IQR].
Results: There was less concealment of laryngeal structures with the Tritube than with the MLT; 7 [6 to 9] vs. 22 [18 to 27] %, (P < 0.001). Surgical conditions were rated comparably (P = 0.06). A subgroup of residents in training perceived surgical conditions to be better with the Tritube compared with the MLT (P = 0.006). Respiratory system compliance with the Tritube was higher at 61 [52 to 71] vs. 46 [41 to 51] ml cmH2O (P < 0.001), plateau pressure was lower at 14 [13 to 15] vs. 17 [16 to 18] cmH2O (P < 0.001), and change of end-expiratory lung volume was higher at 681 [463 to 849] vs. 414 [194 to 604] ml, (P = 0.023) for Tritube-FCV compared with MLT-VCV.
Conclusion: During laryngeal surgery a Tritube improves visibility of the surgical site but not surgical conditions when compared with a MLT 6.0. FCV improves lung aeration and respiratory system compliance compared with VCV.
Trial Registry Number: DRKS00013097.
Airway management during unusual tracheal stenosis: A clinical feasibility trial.
Altun D, Canbaz M, Altun D, Sen C, Camci E Laryngoscope Investig Otolaryngol. 2023; 8(5):1169-1177.
PMID: 37899870 PMC: 10601558. DOI: 10.1002/lio2.1151.
Sharma A, Chandnani N, Vincent N, Goyal S Indian J Otolaryngol Head Neck Surg. 2023; 75(3):2595-2597.
PMID: 37636715 PMC: 10447684. DOI: 10.1007/s12070-023-03536-4.
Syrafe M, Kohne W, Borgers A, Lowen H, Krege S, Groeben H Intensive Care Med Exp. 2023; 11(1):49.
PMID: 37563521 PMC: 10415243. DOI: 10.1186/s40635-023-00537-z.
Grassetto A, Pettenuzzo T, Badii F, Barzaghi F, Carlon R, Dellarole S J Anesth Analg Crit Care. 2023; 2(1):39.
PMID: 37386531 PMC: 9411832. DOI: 10.1186/s44158-022-00066-3.
Bronchoscope-assisted Tritube® placement for resection of sequential tracheal stenosis.
Meierhans R, Gelpke H, Hetzel J, Madjdpour C Anaesth Rep. 2022; 10(2):e12195.
PMID: 36439297 PMC: 9681651. DOI: 10.1002/anr3.12195.